- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05962411
Effects of Dress by Adolescents on Electronic Cigarette Retailer Behaviors in China
August 1, 2024 updated by: Peking University
A Large-Scale Randomized Control Trial to Determine the Effects of Dress by Adolescents on Electronic Cigarette Retailer Behaviors in Regulation Compliance in China
This study is a national-level randomized control trial to measure the effects of dressing in professional attire by adolescents on regulation compliance-related behaviors of electronic cigarette (e-cigarette) retailers defined by both age verification and potential underage sales.
The corresponding null hypothesis that will be tested is that dressing in professional attire by adolescents will have no effect upon retailer behaviors in regulation compliance.
The secondary objectives are to determine the impacts of type of dress by adolescents on marketing and communication strategies adopted by retailers, as well as to document the differences in the behaviors between e-cigarette and tobacco retailers.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Electronic cigarette (e-cigarette) use has been growing dramatically and poses a significant public health threat to adolescents in China.
After the online sales of these products has been banned, purchases from brick-and-mortar stores became the only legal option for the users.
However, little research has been conducted to document sales behaviors of the physical retailers and identify the associated factors.
The study will investigate the extent to which dressing in professional attire by adolescents on regulation compliance in retailer behaviors, including inquiring about age, requesting identity cards for age verification, and completing transactions even when identity cards are not presented.
Adopting the simulated client method, the study will collect information on regulation compliance, store environment, product availability, and marketing strategies through interacting with retailers across China.
Considering that e-cigarette retailers are predominately located in the most densely populated cities, the investigators will include approximately 1,080 e-cigarette retailers from 36 cities, including 4 municipalities directly under the Central Government, 27 provincial capital cities, and 5 cities specially designated in the state plan.
Store addresses and contact information will be obtained through web scraping from the AutoNavi map (the most popular map app in China).
The investigators plan to randomly sample 32 retailers in each city if the number allows, and cities with less than 32 retailers identified will all be included.
To capture reality, retailers will not be informed during visit.
The sampled ones within each city will be randomized into the intervention and control group, with a balance gender ratio of the simulated clients.
These clients will be recruited from university students younger than 20 years old, who can easily be considered as minors (under 18) when purely judged by their appearance.
Clients visiting retailers in the control group will dress in school uniforms and carry a school bag, while those in the intervention group will dress in professional attire with a business-style backpack for males or a leather bag for females.
The clients will record retailer responses, including (1) inquiring about age verbally, (2) requesting identity cards for age verification, and (3) whether retailers still sell products even when identity cards are not presented.
For each e-cigarette retailer, the nearest tobacco retailer identified through the AutoNavi Map will be used for comparison to document the differences in the behaviors between the two types of retailers.
Additionally, communication and marketing strategies, e.g., mentioning available flavored products, dissuading clients not to purchase, are also collected.
Study Type
Interventional
Enrollment (Actual)
1089
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100191
- 36 major metropolitan areas (Beijing included)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Retailers can be identified from the AutoNavi Map through keyword searches
- Retailers have reachable contact information
- Retailers are contacted and claim being open for business on a regular basis
- Include only one retailer if multiple ones have the same contact information
Exclusion Criteria:
- Retailers that are not located in main districts of the cities (usually old town and economically developed central areas)
- Perceived danger surrounding the retailers (e.g., remote alleys with no pedestrians at all)
- Closed when arriving
- Retailers that cannot be located based on map information
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Dress in School Uniforms
Simulated clients dress in school uniforms, enter e-cigarette stores, and act as minor buyers.
|
|
|
Experimental: Dress in Professional Attire
Simulated clients dress in business casuals, enter e-cigarette stores, and act as potential "adult e-cigarette buyers".
|
"Adolescents" pretend to be "adult e-cigarette buyers" by dressing in professional attire.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Non-compliant sales
Time Frame: During visit (day 1)
|
The simulated clients will report whether retailers sell e-cigarette products to possible minors even when identity cards are not presented for age verification.
|
During visit (day 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Inquiring about age
Time Frame: During visit (day 1)
|
The simulated clients will report whether retailers inquire about their age verbally in stores.
|
During visit (day 1)
|
|
Requesting identity cards
Time Frame: During visit (day 1)
|
The simulated clients will report whether retailers request them to show identity cards for the purpose of age verification.
|
During visit (day 1)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Online contact
Time Frame: During visit (day 1)
|
The simulated clients will report if they are able to add retailers as WeChat (the online most popular chat app in China) contacts.
|
During visit (day 1)
|
|
Delivery service offered
Time Frame: During visit (day 1)
|
The simulated clients will report if salespersons mention that products ordered online can be delivered to them.
|
During visit (day 1)
|
|
Illegal flavored e-cigarette products available
Time Frame: During visit (day 1)
|
The simulated clients will report if salespersons mention that flavored (non-national-standard) e-cigarette products are available in stores.
|
During visit (day 1)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Yang Wang, PhD, Peking University Health Science Center
- Principal Investigator: Hai Fang, PhD, Peking University Health Science Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 29, 2023
Primary Completion (Actual)
September 3, 2023
Study Completion (Actual)
September 3, 2023
Study Registration Dates
First Submitted
July 18, 2023
First Submitted That Met QC Criteria
July 25, 2023
First Posted (Actual)
July 27, 2023
Study Record Updates
Last Update Posted (Actual)
August 6, 2024
Last Update Submitted That Met QC Criteria
August 1, 2024
Last Verified
July 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 21-430
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.